biote Corp (BTMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, biote Corp (BTMD) has a cash flow conversion efficiency ratio of -0.081x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.90 Million) by net assets ($-47.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BTMD defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
biote Corp - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how biote Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
biote Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of biote Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tu Liem Urban Development JSC
VN:NTL
|
-0.024x |
|
Shanghai Lingang Holdings Co Ltd B
SHG:900928
|
-0.013x |
|
Miko NV
BR:MIKO
|
0.072x |
|
Income Opportunity Realty Investors
NYSE MKT:IOR
|
-0.001x |
|
Kingdom Holdings Limited
F:K7A
|
-0.105x |
|
InnoTec TSS AG
F:TSS
|
0.029x |
|
Visaka Industries Limited
NSE:VISAKAIND
|
0.060x |
|
Big Ridge Gold Corp
V:BRAU
|
-0.080x |
Annual Cash Flow Conversion Efficiency for biote Corp (2019–2025)
The table below shows the annual cash flow conversion efficiency of biote Corp from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market value of biote Corp.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-50.40 Million | $35.19 Million | -0.698x | -57.75% |
| 2024-12-31 | $-102.20 Million | $45.24 Million | -0.443x | +39.82% |
| 2023-12-31 | $-36.55 Million | $26.88 Million | -0.736x | -568.12% |
| 2022-12-31 | $-58.27 Million | $-9.16 Million | 0.157x | -98.08% |
| 2021-12-31 | $4.12 Million | $33.72 Million | 8.175x | +628.21% |
| 2020-12-31 | $-17.07 Million | $26.43 Million | -1.548x | -100.99% |
| 2019-12-31 | $-32.93 Million | $25.35 Million | -0.770x | -- |
About biote Corp
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with … Read more